GERMANTOWN, Md.--(BUSINESS WIRE)--Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX), today announced that Alan Walton, Ph.D., D.Sc., age 71, has resigned from the Avalon Pharmaceuticals’ Board of Directors effective November 1, 2007. Dr. Walton is a co-founder of Avalon and has served with tireless distinction as the Company’s Chairman from its inception in 1999 until July of this year when Bradley G. Lorimier assumed the Chairman’s role.
